You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Strides Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has two hundred and forty-five approved drugs.

There are three tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma
US Patents:0
Tradenames:153
Ingredients:149
NDAs:245
Patent Litigation for Strides Pharma: See patent lawsuits for Strides Pharma

Drugs and US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 202702-004 Jun 3, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma FUROSEMIDE furosemide TABLET;ORAL 018415-002 Jul 27, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma ETHOSUXIMIDE ethosuximide CAPSULE;ORAL 211928-001 Feb 19, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040191-002 Dec 17, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma ATENOLOL atenolol TABLET;ORAL 074099-001 Apr 28, 1992 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma GLYBURIDE (MICRONIZED) glyburide TABLET;ORAL 074591-002 Dec 22, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,105,776 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-001 Approved Prior to Jan 1, 1982 5,238,924 ⤷  Try a Trial
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 6,143,775 ⤷  Try a Trial
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 5,583,152 ⤷  Try a Trial
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 4,859,692 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,215,104 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
➤ Subscribe Tablets 10 mg and 20 mg ➤ Subscribe 2008-02-29
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.